The Cimicifuga preparation BNO 1055 vs. conjugated estrogens in a double-blind placebo-controlled study: effects on menopause symptoms and bone markers.
about
Differentiated Evaluation of Extract-Specific Evidence on Cimicifuga racemosa's Efficacy and Safety for Climacteric ComplaintsBlack cohosh (Cimicifuga spp.) for menopausal symptomsSafety and efficacy of black cohosh and red clover for the management of vasomotor symptoms: a randomized controlled trialHerbal medicine for the management of polycystic ovary syndrome (PCOS) and associated oligo/amenorrhoea and hyperandrogenism; a review of the laboratory evidence for effects with corroborative clinical findingsGene expression profiling reveals effects of Cimicifuga racemosa (L.) NUTT. (black cohosh) on the estrogen receptor positive human breast cancer cell line MCF-7.Black cohosh (Actaea racemosa) for the mitigation of menopausal symptoms: recent developments in clinical safety and efficacy.60 years of Cimicifuga racemosa medicinal products : Clinical research milestones, current study findings and current developmentEfficacy of black cohosh (Cimicifuga racemosa L.) in treating early symptoms of menopause: a randomized clinical trial.The safety and tolerance of phytotherapies in menopausal medicine - a review of the literatureEffect of black cohosh (cimicifuga racemosa) on vasomotor symptoms in postmenopausal women: a randomized clinical trialEfficacy and safety of remifemin on peri-menopausal symptoms induced by post-operative GnRH-a therapy for endometriosis: a randomized study versus tibolone.Metabolism of Nω -methylserotonin, a serotonergic constituent of black cohosh (Cimicifuga racemosa, L. (Nutt.)), by human liver microsomesBlack cohosh and breast cancer: a systematic review.Black Cohosh: Insights into its Mechanism(s) of Action.Black cohosh does not exert an estrogenic effect on the breast.A systematic review of non-hormonal treatments of vasomotor symptoms in climacteric and cancer patientsEvaluation of the botanical authenticity and phytochemical profile of black cohosh products by high-performance liquid chromatography with selected ion monitoring liquid chromatography-mass spectrometry.Botanical and dietary supplements for menopausal symptoms: what works, what does not.Contemporary alternatives to plant estrogens for menopause.Phytoestrogens in botanical dietary supplements: implications for cancer.Cytochrome P450 enzyme mediated herbal drug interactions (Part 2)Cimicifuga species identification by high performance liquid chromatography-photodiode array/mass spectrometric/evaporative light scattering detection for quality control of black cohosh products.Mass spectrometric dereplication of nitrogen-containing constituents of black cohosh (Cimicifuga racemosa L.).Treatment of Insomnia, Insomnia Symptoms, and Obstructive Sleep Apnea During and After Menopause: Therapeutic ApproachesDose-Dependent Effects of the Cimicifuga racemosa Extract Ze 450 in the Treatment of Climacteric Complaints: A Randomized, Placebo-Controlled Study.Potential antiosteoporotic agents from plants: a comprehensive review.In vitro metabolic interactions between black cohosh (Cimicifuga racemosa) and tamoxifen via inhibition of cytochromes P450 2D6 and 3A4.Alternative therapies for osteoporosis.Black cohosh (Actaea racemosa, Cimicifuga racemosa) behaves as a mixed competitive ligand and partial agonist at the human mu opiate receptor.Non-estrogenic approaches for the treatment of climacteric symptoms.Chlorination diversifies Cimicifuga racemosa triterpene glycosides.Treatment of vasomotor symptoms in the menopausal transition and postmenopausally: psychiatric comorbidity.Black cohosh and St. John's wort (GYNO-Plus) for climacteric symptomsPhytoestrogens impact on menopausal symptomatologyNitrogen-Containing Constituents of Black Cohosh: Chemistry, Structure Elucidation, and Biological Activities.Current alternative and complementary therapies used in menopause.Role of the ER/NO/cGMP Signaling Pathway in the Promotion of Osteogenic Differentiation of Rat Bone Marrow Mesenchymal Stem Cells by Actaea racemosa Extract.Non-hormonal treatment strategies for vasomotor symptoms: a critical review.Use of gabapentin for the management of natural or surgical menopausal hot flashes.Non-estrogen conventional and phytochemical treatments for vasomotor symptoms: what needs to be known for practice.
P2860
Q21284761-BB4D4B13-A4A6-4A5F-951A-5031A843AC25Q24200366-14A771BC-AF9A-4B44-8073-6E46A19A8C8FQ24650609-4CD54513-49E1-45C0-B5A9-D706A47DF99BQ27002469-A3CA5940-1D1E-4E25-ADE6-9854DD491564Q33299627-4D630A42-DE04-4B74-8A94-9DFB10F574D8Q33508670-933B6DDA-9160-47B7-90D6-A2ECFE820FE9Q33617433-01D26650-EAB8-4F9F-BC82-6E0BFEBAEE3BQ33644285-AC835107-0264-4C92-9B99-55CF83F0C40DQ33704848-E03B2B9E-BF7F-483F-8FA1-1E83690FE1FEQ34164486-FD559B47-113C-4BF8-930B-23EFE0401911Q34413207-82747B39-D39B-4373-9F8D-EC363202FC9DQ34498740-244CC1F3-D2AD-498C-A538-D2CA30EC050CQ34601209-855031B0-8F6A-454E-BFC5-FBDC4A8E7B29Q34611442-7E8B6846-E77D-4BFC-872C-AE634A7DAB5FQ34713601-D9CB3F6E-24CE-48DC-9C3E-02892CD422A4Q35092002-72657943-DE35-408E-810E-ED420DD91AF2Q35479350-E2E9E0D4-42CC-43F2-B6DD-18657C9525EEQ35574718-0A3E7987-74C4-4CD3-9015-2FDB7AA3C939Q35606932-744C93AC-8650-45B7-BCE6-ED3C684F87EDQ35702422-73855EAC-54FD-441B-A9FA-4168A9AC449CQ35729029-6926420B-74E5-45EC-8044-945F4B499C11Q35740974-A21D0322-DE38-4964-9CD7-F08A10ABF624Q35926001-C667E60C-E9B4-4FF3-AA31-6C40B6EF9325Q36165434-7F9FB959-16C9-40E5-8731-4287B78680D3Q36529670-2730B5F6-B03D-44CE-B64A-76B4C085E032Q36550932-E62D16B4-465B-42C3-89B1-A529F587B3A6Q36589050-DCD93100-C65E-41A5-BF8E-9410B15254FFQ36642341-3FD5AEFD-40C0-4AC7-8CC2-459A57AA1BF3Q36900049-8E35B87A-524B-4122-9E56-680DB8AC3EAFQ36946834-22C7930C-6B3A-43CF-95D0-B5B44DCFAE86Q36999529-A37524F6-1786-451B-B15A-752218DBC8CCQ37014593-6BD2676F-3084-4C71-8389-8A9F50635870Q37065520-C862B6B6-4802-49DE-9DA4-FB3F27B8569AQ37160575-3CB92F8F-6DEA-4D42-A4CC-22A5F2D1F2F4Q37375330-2BC27AFE-F6A5-435D-9456-2A7CD4924F9EQ37434162-289033E1-1A6E-4CD3-95CB-05D54B64264FQ37448608-7C033350-3D99-43F1-927A-8E5BC8E2B8FBQ37841545-B10331B1-5732-4446-9FA6-3BA5AB3AD59FQ37846004-84B09F0B-715C-439E-881D-288DF8226B5AQ37965541-56EF80A3-F495-4767-9243-6830EA17C8D9
P2860
The Cimicifuga preparation BNO 1055 vs. conjugated estrogens in a double-blind placebo-controlled study: effects on menopause symptoms and bone markers.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
The Cimicifuga preparation BNO ...... use symptoms and bone markers.
@en
The Cimicifuga preparation BNO ...... use symptoms and bone markers.
@nl
type
label
The Cimicifuga preparation BNO ...... use symptoms and bone markers.
@en
The Cimicifuga preparation BNO ...... use symptoms and bone markers.
@nl
prefLabel
The Cimicifuga preparation BNO ...... use symptoms and bone markers.
@en
The Cimicifuga preparation BNO ...... use symptoms and bone markers.
@nl
P2093
P1433
P1476
The Cimicifuga preparation BNO ...... use symptoms and bone markers.
@en
P2093
Seidlová-Wuttke D
P304
P356
10.1016/S0378-5122(02)00350-X
P478
44 Suppl 1
P577
2003-03-01T00:00:00Z